Teva Pharmaceutical Industries (NYSE:TEVA) Price Target Raised to $30.00
Teva Pharmaceutical Industries (NYSE:TEVA – Free Report) had its price target raised by UBS Group from $28.00 to $30.00 in a research note published on Thursday,Benzinga reports. UBS Group currently ...
FTAI SHAREHOLDER ALERT: FTAI Aviation Ltd. Investors with Losses are Urged to Contact BFA Law by March 18 about Ongoing Class Action
The news caused a significant decline in the price of FTAI Aviation stock. On January 15, 2025, the price of the company's stock fell 24%, from a closing price of $153.29 per share on January 14, 2025 ...
globes.co.il13h
Sun: NICE Systems jumps
NICE Systems Ltd. (Nasdaq: NICE; TASE: NICE) rose 6.16% for the biggest rise on the Tel Aviv 35 Index today. Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA rose 1.75%, Ormat Technologies ...
BIOA SHAREHOLDER ALERT: BioAge Labs Investors with Losses are Urged to Contact BFA Law by March 10 about Ongoing Class Action
In truth, BioAge was forced to discontinue the STRIDES Phase 2 trial after several subjects exhibited elevated liver enzyme levels, indicating potential organ damage. Consequently, the Company ...
Earnings week ahead: TSLA, META, AAPL, MSFT, INTC, MA, XOM, LUV and more
As the earnings season gains momentum, investors are gearing up for reports from a diverse array of companies, spanning such ...
centerforbiosimilars18h
Eye on Pharma: Teva, Formycon, Celltrion Biosimilar Updates in Global Markets
Three players in the biosimilar space have already sparked hope for the new year, with each having big business or regulatory ...